Association ofTERTPromoter Mutation 1,295,228 C>T WithBRAFV600E Mutation, Older Patient Age, and Distant Metastasis in Anaplastic Thyroid Cancer
Anaplastic thyroid cancer
DOI:
10.1210/jc.2014-3606
Publication Date:
2015-01-13T16:13:14Z
AUTHORS (16)
ABSTRACT
The aggressive role of TERT promoter mutations has been well established in differentiated thyroid cancer but not anaplastic (ATC).We tested the mutation status by sequencing genomic tumor DNA and examined its relationship with clinicopathological characteristics ATC.Among 106 American Chinese ATC samples, 1,295,228 C>T (termed C228T) was found 37 (34.9%) cases, 1,295,250 four cases (3.8%), two were mutually exclusive collectively 41 (38.7%). C228T occurred 28 90 (31.1%) wild-type BRAF vs nine 16 (56.3%) V600E an odds ratio 2.85 (95% confidence interval, 0.96-8.42; P = .05). Patient age 67.6 ± 13.6 61.6 11.4 years patients (P .02), demonstrating association between older patient age. This also seen within cohort. In this cohort, which had more available data, associated distant metastasis tumor; specifically, 15 18 (83.3%) eight 26 (30.8%) patients, 11.25 2.53-50.08; .001). No sex, size, lymph node metastasis, extrathyroidal invasion ATC.This is largest study on ATC, V600E, age, ATC.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (71)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....